| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7333a9700d96ba02d498fa22f82b9067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_364361dcadbe698011b0554cccff370b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77c59e3f92515676eb9718550bf2c0da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2007-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ee96544bef199f2f52359f48c56a04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49ea74e430e32f76e36d6a4bace277ad |
| publicationDate |
2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007143507-A3 |
| titleOfInvention |
Preparation and utility of substituted erythromycin analogs |
| abstract |
The present disclosure is directed to novel macrolide antibiotics of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof; and the chemical syntheses and medical uses of these novel macrolide antibiotics for the treatment and/or management of infections caused by various aerobic and anaerobic gram-positive and gram-negative microorganisms as well as various mycobacteria. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9200026-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9480679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9453042-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439918-B2 |
| priorityDate |
2006-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |